Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY (unaudited)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain
Accumulated Deficit
Balance at Dec. 31, 2022 $ 127,736 $ 20 $ 685,847 $ 102 $ (558,233)
Balance (in shares) at Dec. 31, 2022   20,263,116      
Vesting of restricted stock units, Shares   111,023      
Exercise of prefunded warrants, Shares   34,991      
Stock-based compensation expense 2,645   2,645    
Other comprehensive gain 161     161  
Net loss (23,789)       (23,789)
Balance at Mar. 31, 2023 106,753 $ 20 688,492 $ 263 (582,022)
Balance (in shares) at Mar. 31, 2023   20,409,130      
Balance at Dec. 31, 2023 $ 16,662 $ 26 739,443   (722,807)
Balance (in shares) at Dec. 31, 2023 26,448,678 26,448,678      
Vesting of restricted stock units, Shares   279,659      
Stock-based compensation expense $ 2,103   2,103    
Net loss (3,708)       (3,708)
Balance at Mar. 31, 2024 $ 15,057 $ 26 $ 741,546   $ (726,515)
Balance (in shares) at Mar. 31, 2024 26,728,337 26,728,337